Antidiabetic effects of a standardized Egyptian rice bran extract

Phytotherapy Research

Volumn 27, Issue 2, 2013, Pages 264-271

  Kaup, Rebecca M ^a   Khayyal, Mohamed T ^b   Verspohl, Eugen J ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

oryzanol; diabetes; policosanol; rice bran; tocotrienol

Indexed keywords

ALPHA TOCOTRIENOL; ANTIDIABETIC AGENT; FERULIC ACID; GAMMA ORYZANOL; GAMMA TOCOTRIENOL; GLIBENCLAMIDE; GLUCOSE; INSULIN; PLANT EXTRACT; POLICOSANOL; RICE BRAN EXTRACT; TOCOPHEROL DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; APOPTOSIS; ARTICLE; CELL STRAIN HEPG2; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ISOLATION; EGYPT; FEMALE; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; MALE; NONHUMAN; PROTEIN DETERMINATION; RAT; RICE BRAN; TUMOR CELL;

ANIMALS; BLOOD GLUCOSE; CHROMANS; COUMARIC ACIDS; DIETARY SUPPLEMENTS; FATTY ALCOHOLS; FEMALE; GLUCOSE TOLERANCE TEST; HEP G2 CELLS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; ORYZA SATIVA; PHENYLPROPIONATES; PLANT EXTRACTS; RATS; TOCOTRIENOLS; TUMOR NECROSIS FACTOR-ALPHA; VITAMIN E;

RATTUS;

EID: 84873414467     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.4705     Document Type: Article

References (45)

1. Aden DP, Fogel A, Plotkin S, Damjanov I, Knowles BB,. 1979. Controlled synthesis of HbsAg in a differentiated human liver carcinoma-derived cell line. Nature 282 (5739): 615-616.
2. Adisakwattana S, Moonsan P, Yibchok-Anun S,. 2008. Insulin-releasing properties of a series of cinnamic acid derivatives in vitro and in vivo. J Agric Food Chem 56: 7838-7844.
3. Asfari M, Janjic D, Meda P, Li G, Halban PA, Wollheim CB,. 1992. Establishment of 2-mercaptoethanol-dependent differential insulin secreting cell lines. Endocrinology 130: 167-178.
4. Baliarsingh S,. 2005. The therapeutic impacts of tocotrienols in type 2 diabetic patients with hyperlipidemia. Atheriosclerosis 182: 367-374.
5. Balz M, Schulte E, Thier HP, et al,. 1992. Trennung von tocopherolen und tocotrienolen durch HPLC. Fat Sci Technol 94: 209-213.
6. Castano G, Fernandez L, Mas R, Illnait J, Mesa M, Fernandez JC,. 2003. Comparison of the effects of policosanol and atorvastatin on lipid profile and platelet aggregation in patients with dyslipidemia and type 2 diabetes mellitus. Clin Drug Invest 23: 639-650.
7. Chen CW, Cheng HH,. 2006. A rice bran oil diet increases LDL-receptor and HMG-CoA reductase mRNA expressions and insulin sensitivity of rats with streptozotocin/nicotinamide-Induced Type 2 Diabetes. J Nutr 136: 1472-1476.
8. Cheng HH, Huang HY, Chen YY, et al,. 2010a. Ameliorative effects of stabilized rice bran on type 2 diabetes patients. Ann Nutr Metab 56: 45-51.
9. Cheng HH, Ma CY, Chou TW, Chen YY, Lai MH,. 2010b. Gamma-oryzanol ameliorates insulin resistance and hyperlipidemia in rats with streptozotocin/nicotinamide-induced type 2 diabetes. Int J Vitam Nutr Res 80: 45-53.
10. Chou TW, Ma CY, Cheng HH, Chen YY, Lai MH,. 2009. A rice bran oil diet improves lipid abnormalities and suppress hyperinsulinemic responses in rats with streptozocinnicotinamide-induced type 2 diabetes. J Clin Biochem Nutr 45: 29-36.
11. Cicero AFG, Gaddi A,. 2001. Rice bran oil and γ-oryzanol in the treatment of hyperlipoproteinaemias and other conditions. Phytother Res 15: 277-289.
12. Crespo N, Alvarez R, Mas R, Illnait J, Fernandez L, Fernandez JC,. 1997. Effects of policosanol on patients with non-insulin-dependent diabetes mellitus and hypercholesterolemia: a pilot study. Curr Ther Res 58: 44-51.
13. Deutschländer MS, Lall N, Van de Venter M, Hussein AA,. 2011. Hypoglycemic evaluation of a new triterpene and other compounds isolated from Euclea undulata Thunb. var. myrtina (Ebenaceae) root bark. J Ethnopharmacol 133: 1091-1095.
14. Fang F, Kang Z, Wong C,. 2010. Vitamin E Tocotrienols improve insulin sensitivity through activating peroxisome proliferator-activated receptors. Mol Nutr Food Res 54: 345-352.
15. Frede W,. 2006. Taschenbuch für Lebensmittelchemiker. (2. Auflage). Springer Verlag: Berlin, S. 566.
16. Hernandez R, Teruel T, de Alvaro C, Lorenzo M,. 2004. Rosiglitazone ameliorates insulin resistance in brown adipocytes of Wistar rats by impairing TNF-α induction of p38 and p42/p44 mitogen-activated protein kinases. Diabetologia 47: 1615-1624.
17. Iqbal J, Minhajuddin M, Beg ZH,. 2003. Suppression of 7,12-dimethylbenz[alpha]anthracene-induced carcinogenesis and hypercholesterolaemia in rats by tocotrienol-rich fraction isolated from rice bran oil. Eur J Cancer Prev 12: 447-453.
18. Jun HG, Lee GS, Lee SH,. 2004. γ-Oryzanol for lowering blood glucose level. Repub Korean Kongkae Taeho Kongbo KR 2004008830 A 20040131.
19. Jung EH, Kim SR, Hwang IK, Ha TY,. 2007. Hypoglycemic effects of a phenolic acid fraction of rice bran and ferulic acid in C57BL/KsJ-db/db-mice. J Agric Food Chem 55: 9800-9804.
20. Kannan A, Hettiarachchy N, Johnson MG, Nannapaneni R,. 2008. Human colon and liver cancer cell proliferation inhibition by peptide hydrolysates derived from heat stabilized defatted rice bran. J Agric Food Chem 56: 11643-11647.
21. Lai KK, Lorca GL, Gonzalez CF,. 2009. Biochemical properties of to cinnamoyl esterases purified from a Lactobacillus johnsonii strain isolated from stool samples of diabetes-resistant rats. Appl Environm Microbiology 75: 5018-5024.
22. Lee S-H, Chun H-K, Chang S-O, Lee Y-S,. 2004. Effect of γ-oryzanol on blood glucose in diabetic KK mice. Hanguk Sik Yong Kwahak Hoechi 33: 827-831.
23. Mäkynen K, Chitchumroonchokchai C, Adisakwattana S, Failla M, Ariyapitipun T,. 2012. Effect of gamma-oryzanol on the bioaccessibility and synthesis of cholesterol. Eur Rev Med Pharmacol Sci 16: 49-56.
24. Mandal S, Barik B, Mallick C, De D, Ghosh D,. 2008. Therapeutic effect of ferulic acid, an ethereal fraction of ethanolic extract of seed of Syzygium cumini against streptozotocin-induced diabetes in male rat. Methods Find Exp Clin Pharmacol 30: 121-128.
25. Nagasaka R, Hori M,. 2009. New bioactive functions and applications of γ-oryzanol, a component of rice bran. Preventive and therapeutic effects via NF-κB-inhibitory action of diabetes, ulcerative colitis etc. are expected. Kagaku to Seibutsu 47: 816-818.
26. Nam SH, Choi SP, Kang MY, Kozukue N, Friedman M,. 2005. Antioxidative, antimutagenic and anticarcinogenic activities of rice bran extracts in chemical and cell assays. J Agric Food Chem 53: 816-822.
27. Nomura E, Kashiwada A, Hosoda A, et al,. 2003. Synthesis of amide compounds of ferulic acid and their stimulatory effects on insulin secretion in vitro. Bioorg Med Chem 11: 3807-3813.
28. Ohnishi M, Matuo T, Tsuno T, et al,. 2004. Antioxidant activity and hypoglycemic effect of ferulic acid in STZ-induced diabetic mice and KK-Ay mice. Biofactors 21: 315-319.
29. Prabhakar and Doble. 2011. Interaction of cinnamic acid derivatives with commercial hypoglycemic drugs on 2-deoxyglucose uptake in 3T3-L1 adipocytes. J Agric Food Chem 59: 9835-9844.
30. Qureshi AA, Mo H, Packer L, Peterson DM,. 2000. Isolation and identification of novel tocotrienols from rice bran with hypocholesterolemic, antioxidant and antitumor properties. J Agric Food Chem 48: 3130-3140.
31. Qureshi AA, Sami SA, Khan FA,. 2002a. Effects of stabilized rice bran, its soluble and fiber fractions on blood glucose levels and serum lipid parameters in humans with diabetes mellitus types I and II. J Nutr Biochem 13: 175-187.
32. Qureshi AA, Sami SA, Salser WA, Khan FA,. 2002b. Dose-dependent suppression of serum cholesterol by tocotrienol-rich fraction (TRF25) of rice bran in hypercholesterolemic humans. Atherosclerosis 161: 199-207.
33. Raghavan PR,. 2010. Policosanol nanoparticles for treatment of various disorders including diabetes. PCT Int. Appl. (patent).
34. Schulte E, Balz M, Thier HP, et al,. 1989. Schnelle Herstellung der Fettsäuremethylester aus Fetten mit Trimethylsulfoniumhydroxid oder Natriummethylat. Fat Sci Technol 5: 181-183.
35. Siddiqui S, Rashid Khan M, Siddiqui WA,. 2010. Comparative hypoglycemic and nephroprotective effects of tocotrienol rich fraction (TRF) from palm oil and rice bran oil against hyperglycemia induced nephropathy in type 1 diabetic rats. Chem Biol Interact 188: 651-658.
36. Son MJ, Rico CW, Nam SH, Kang MY,. 2011. Effect of oryzanol and ferulic acid on the glucose metabolism of mice fed with a high-fat diet. J Food Sci 76: H7-H10.
37. Takumi M, Tanaka T, Takamura Y, Watanabe N,. 2011. Agent for ameliorating type-2 diabetes containing koaliang-derived wax mixture, and food or beverage containing same. PCT Int. Appl. (patent).
38. Torres O, Agramonte AJ, Illnait J, Ferreiro RM, Fernandez L, Fernandez JC,. 1995. Treatment of hypercholesterolemia in NIDDM with policosanol. Diabetes Care 18: 393-398.
39. Verspohl EJ,. 2002. Recommended testing in diabetes research. Planta Med 68: 581-590.
40. Wan Nazaimoon WM, Khalid BA,. 2002. Tocotrienol-rich diet decreases advanced glycosylation end-products in nondiabetic rats and improves glycaemic control in streptozotocin-induced diabetic rats. Malays J Pathol 24: 77-82.
41. Wild S, Roglic G, Green A, Sicree R, King H,. 2004. Global prevalence of diabetes. Diabetes Care 27: 1047-1053.
42. Yap SP, Yuen KH, Wong JW,. 2001. Pharmacokinetics and bioavailability of alpha-, gamma- and delta-tocotrienols under different food status. J Pharm Pharmacol 53: 67-71.
43. Yoshioka K, Takahashi T, Homma T, et al,. 1996. A novel fluorescent derivative of glucose applicable to the assessment of glucose uptake activity of Escherichia coli. Biochim Biophys Acta 1289: 5-9.
44. Zimmet P, Alberti KGMM, Shaw J,. 2001. Global and societal implications of the diabetes epidemic. Nature 414: 782-787.
45. Zou C, Wang Y, Shen Z,. 2005. 2-NBDG as a fluorescent indicator for direct glucose uptake measurement. J Biochem Biophys Methods 64: 207-215.